Ledger.Open graph →
SEC Form D · filed July 24, 2020

Providence Therapeutics Inc

Offering
$3.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CALGARY, Alberta, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Eric Marcusson · San Francisco, CAExecHaiqing Jiang · Mountain View, CAExec · DirectorNelson Rising · Los Angeles, CAExecBradley T. Sorenson · Calgary, Alberta, CanadaExec · DirectorJay Soon · Long Beach, CAExecJohn B. Collis · Boston, MAExec · DirectorKimberlee Nelson · Dallas, TXExecWilliam Graff · Newport Coast, CAExecElisabetta Graff · Newport Coast, CAExecRichard W. Scarinci · Boston, MAExec · DirectorJennifer White · Dallas, TXExecScott Leary · San Diego, CAExec · DirectorNatalia Orozco · Toronto, Ontario, CanadaExecKenneth Hughes · Calgary, Alberta, CanadaExecScott Mcmullin · Los Angeles, CAExecAntonella Graziano · Luxembourg, LuxembourgExecDarlene Haslam · Calgary, Alberta, CanadaExecScott Robinson · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗